Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 with no changes to study content or features; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page removed the government funding lapse notice, and the core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo changes to core study details (eligibility, endpoints, or schedule); observed differences are formatting and minor copy edits, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating status disclaimer; removed the specific medical term 'B-cell chronic lymphocytic leukemia' from the content.SummaryDifference2%

- Check70 days agoChange DetectedUpdated terminology and taxonomy for leukemia/lymphoma and infections, and bumped revision to v3.1.0; older specific leukemia terms were removed in favor of broader or updated classifications.SummaryDifference0.7%

- Check84 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.1%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.